Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
- Author
- Dr. Neil Love
- Published
- Tue 20 May 2025
- Episode Link
- https://hematologic-oncology.captivate.fm/episode/5369-oncologytodaybispecificlymphomas24
Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.
CME information and select publications here.
